Welcome To
Acadia Broadcasting NewsThe Latest and Greatest ContentYour Trusted Local Source


(Photo: Courtesy of Health Canada)

Nasal spray recalled due to possible bacterial contamination

By Tara Clow Feb 20, 2024 | 11:42 AM

If you have recently been prescribed a nasal spray to treat allergies or sinusitis, check to see if it is included in a Health Canada recall.

Two lots of the 50 microgram bottle of APO-Mometasone nasal spray are impacted.

Health Canada says there’s a risk of bacterial contamination, and the spray could potentially cause infection if used.

The APO-Mometasone nasal spray is a prescription drug used to treat seasonal and year-round nasal allergy symptoms (such as itchy, stuffy, or runny nose and sneezing) in children 3-11 years old. It is also used to treat sinusitis (sinus inflammation) in adults and children 12 years of age and older, and nasal polyps in adults.

Health Canada says if you have used the affected product, monitor for symptoms and seek medical attention if you are experiencing persistent or worsening symptoms, such as fevers, facial pain, or pressure.

You should also return the product to your local pharmacy for proper disposal.